Your browser doesn't support javascript.
loading
Performance of a Novel Research-Use-Only Secretoneurin ELISA in Patients with Suspected Acute Coronary Syndrome: Comparison with an Established Secretoneurin Radioimmunoassay.
Myhre, Peder L; Ottesen, Anett H; Faaren, Arne L; Tveit, Sjur H; Springett, Jon; Pyylampi, Johanna; Stridsberg, Mats; Christensen, Geir; Høiseth, Arne Didrik; Omland, Torbjørn; Røsjø, Helge.
Afiliação
  • Myhre PL; Division of Medicine, Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
  • Ottesen AH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Faaren AL; Division for Research and Innovation, Akershus University Hospital, Lørenskog, Norway.
  • Tveit SH; Institute for Experimental Medical Research, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Springett J; CardiNor, Oslo, Norway.
  • Pyylampi J; Division of Medicine, Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
  • Stridsberg M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Christensen G; Bioventix, Farnham, United Kingdom.
  • Høiseth AD; Kaivogen, Turku, Finland.
  • Omland T; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Røsjø H; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Cardiology ; 146(5): 566-574, 2021.
Article em En | MEDLINE | ID: mdl-34284402

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Ensaio de Imunoadsorção Enzimática / Secretogranina II / Síndrome Coronariana Aguda Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cardiology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Ensaio de Imunoadsorção Enzimática / Secretogranina II / Síndrome Coronariana Aguda Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cardiology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega